Himalaya Doubles Down on AI Applications, AI Audio Large Model Gains National Approval, Empowering Content Creation and DistributionHimalaya is stepping up its use of AI technology and has made significant progress. Recently, Yu Jianjun, founder and CEO of Himalaya, stated at the second "AIINALL Innovation and Entrepreneurship Competition" that he hopes to use the competition to propel Himalaya into becoming a high-quality AI-powered content platform, empowering the creation and distribution of more excellent content...

Recombinant human adenovirus type 5 injection (trade name: Ankrui) is an oncolytic adenovirus anti-tumor drug that contains recombinant adenoviruses that can specifically replicate in tumor cells, cause tumor cell damage, lysis, and further activate immune responses to exert anti-tumor effects. Ankeri was approved for marketing in China in 2005, with an approved indication for advanced nasopharyngeal carcinoma...

On Thursday (June 8th) in the Asian market, Bitcoin's short-term momentum remained volatile and downward, with the currency price dropping to $26338. The US media reported overnight that the List of courts of the United States had approved the freezing of US assets, but it was later changed to "to be confirmed", and the official did not provide further information updates...